It is said that the clinical manifestations of SYNGAP1 encephalopathy patients with mutations in exons 5 to 19 are heavier than those in exons 1–4, and the prognosis of drug treatment is worse [2, 5]. Here, SYNGAP1 is linked to Encephalopathy.